INS and type 1 diabetes mellitus: Consistent with these studies, systemic administration of the autophagy activator rapamycin to Akita mice, a type 1 diabetes model with misfolded proinsulin accumulation, ameliorates diabetic phenotypes through activating autophagy and reducing ER stress and β cell apoptosis (Bachar-Wikstrom et al., 2013).